Clinical Trial Update: Dorzagliatin in Pancreatic Insufficient Cystic Fibrosis [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating dorzagliatin in pancreatic insufficiency and cystic fibrosis-related diabetes is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis-related Diabetes
• Pancreatic Insufficiency

Drugs mentioned

• Dorzagliatin (dorzagliatin)

Snippet

Sponsor: University of Pennsylvania | Conditions: Pancreatic Insufficiency, Cystic Fibrosis-related Diabetes | Phase 1 | Status: RECRUITING